Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy

(2010) Olivier Glehen et al.   ANNALS OF SURGICAL ONCOLOGY

Surgical responsibilities in the management of peritoneal carcinomatosis

(2010) Paul H. Sugarbaker   JOURNAL OF SURGICAL ONCOLOGY

Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery

(2009) Yutaka Yonemura et al.   JOURNAL OF SURGICAL ONCOLOGY

Evidence-based medicine in the treatment of peritoneal carcinomatosis: Past, present, and future

(2009) Aviram Nissan et al.   JOURNAL OF SURGICAL ONCOLOGY

Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: A single western center experience

(2008) S. Scaringi et al.   EJSO

Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis

(2008) Hassan Alaa Hammed al-Shammaa et al.   WORLD JOURNAL OF GASTROENTEROLOGY